Shubao slimming capsules contain illegal Fenfluramine and Nitrosofenfluramine

Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.

Fenfluramine is an appetite suppressant which was banned globally on health grounds in 1997 due to concerns about the drug’s effect on the heart.

Nitrosofenfluramine is known to be toxic to the liver. Globally, the illegal adulteration of slimming products with nitrosofenfluramine and fenfluramine has been associated with a large number of reports of liver toxicity.

In Japan 160 people are known to have been made ill, and four patients have died following the use of several TCM slimming products thought to contain these drugs.

The UK patient required and received a liver transplant.

The Agency is investigating the matter and has seized samples of Shubao from a number of TCM outlets in the UK. All of the samples tested contained nitrosofenfluramine and/or fenfluramine. The amount of the substance(s) varied widely making assessment of the health risk problematic.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine